PL3522876T3 - Sposoby hamowania przemiany choliny w trimetyloaminę (tma) - Google Patents

Sposoby hamowania przemiany choliny w trimetyloaminę (tma)

Info

Publication number
PL3522876T3
PL3522876T3 PL18792732T PL18792732T PL3522876T3 PL 3522876 T3 PL3522876 T3 PL 3522876T3 PL 18792732 T PL18792732 T PL 18792732T PL 18792732 T PL18792732 T PL 18792732T PL 3522876 T3 PL3522876 T3 PL 3522876T3
Authority
PL
Poland
Prior art keywords
tma
trimethylamine
choline
methods
inhibiting conversion
Prior art date
Application number
PL18792732T
Other languages
English (en)
Inventor
Jose Carlos Garcia-Garcia
George Franklin Gerberick
Michael Reilly
Stanley Leon Hazen
Xiaodong Gu
Original Assignee
The Procter & Gamble Company
The Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company, The Cleveland Clinic Foundation filed Critical The Procter & Gamble Company
Publication of PL3522876T3 publication Critical patent/PL3522876T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL18792732T 2017-10-02 2018-10-02 Sposoby hamowania przemiany choliny w trimetyloaminę (tma) PL3522876T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762566975P 2017-10-02 2017-10-02
PCT/US2018/053924 WO2019070676A1 (en) 2017-10-02 2018-10-02 METHODS OF INHIBITING CONVERSION FROM CHOLINE TO TRIMETHYLAMINE (TMA)
EP18792732.2A EP3522876B1 (en) 2017-10-02 2018-10-02 Methods for inhibiting conversion of choline to trimethylamine (tma)

Publications (1)

Publication Number Publication Date
PL3522876T3 true PL3522876T3 (pl) 2021-06-28

Family

ID=63963526

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18792732T PL3522876T3 (pl) 2017-10-02 2018-10-02 Sposoby hamowania przemiany choliny w trimetyloaminę (tma)

Country Status (9)

Country Link
US (1) US10751301B2 (pl)
EP (1) EP3522876B1 (pl)
CN (1) CN111163763B (pl)
AU (1) AU2018345747B2 (pl)
BR (1) BR112020006108A2 (pl)
CA (1) CA3076195C (pl)
MX (1) MX390163B (pl)
PL (1) PL3522876T3 (pl)
WO (1) WO2019070676A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110959862B (zh) * 2019-11-14 2021-08-13 南方医科大学 一种具有清除氧化三甲胺和抗炎功能的组合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1524922A (fr) * 1966-06-01 1968-05-10 Basf Ag Agents entravant la croissance et modifiant l'habitus des plantes
DE1542826B1 (de) * 1966-06-01 1971-04-08 Basf Ag Sulfoniumverbindungen und deren Verwendung
FR1559102A (pl) 1968-01-23 1969-03-07
US3644531A (en) * 1968-08-13 1972-02-22 Sankyo Co 2-propynylsulfonium salts
US3651222A (en) * 1969-09-15 1972-03-21 Monsanto Co Nematocidal use of substituted dimethylsulfonium tetraphenylborates
DE2331185A1 (de) 1973-06-19 1975-01-16 Bayer Ag Mittel zur regulierung des pflanzenwachstums
EP0555058B1 (en) 1992-02-07 1997-05-07 Toyo Ink Manufacturing Co., Ltd. (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition
JP4999043B2 (ja) * 2006-02-13 2012-08-15 株式会社Adeka スルホニウム塩化合物、カチオン重合開始剤および熱硬化性組成物
WO2009073839A1 (en) 2007-12-05 2009-06-11 The Cleveland Clinic Foundation Trimethylamine compounds as risk predictors of cardiovascular disease
AU2013274406B2 (en) * 2012-06-11 2017-02-02 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
WO2017095995A1 (en) 2015-12-01 2017-06-08 The Procter & Gamble Company Methods for inhibiting conversion of carnitine to trimethylamine (tma)
AU2017291211B2 (en) 2016-06-29 2020-06-25 Cleveland Clinic Innovation Methods for inhibiting conversion of choline to trimethylamine (TMA)

Also Published As

Publication number Publication date
EP3522876A1 (en) 2019-08-14
AU2018345747A1 (en) 2020-04-09
BR112020006108A2 (pt) 2020-09-24
AU2018345747B2 (en) 2021-03-18
MX390163B (es) 2025-03-20
WO2019070676A1 (en) 2019-04-11
US10751301B2 (en) 2020-08-25
MX2020003080A (es) 2022-02-18
CN111163763B (zh) 2023-08-22
EP3522876B1 (en) 2021-02-24
CA3076195C (en) 2022-06-21
CN111163763A (zh) 2020-05-15
US20190099384A1 (en) 2019-04-04
CA3076195A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
PL3478276T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
PL3383376T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
IL257219B (en) Prodrugs of glutamine analogs
IL253503B (en) Allele-specific modulators of p23h rhodopsin
EP3212657A4 (en) Methods of preparing substituted nucleoside analogs
PL3221873T3 (pl) System do zabezpieczenia transformatorów typu suchego
GB201507524D0 (en) Improvements to molybdenum containing coatings
PT3334734T (pt) Forma c de avibactam sódico
PL3151351T3 (pl) Udoskonalenia odcinków koryt kablowych
SG11201706503TA (en) System for forming elastomeric compositions for application to metal
ZA201604588B (en) Pretreatment of substrates that have unsaturated units
IL266087A (en) Use of itolizumab to reduce cd6 phosphorylation
GB201607819D0 (en) Secure distribution of an image
PL3522927T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
GB201702388D0 (en) Compositions for application to aerial parts of plants
IL262111A (en) Monovalent inhibitors of hutnfr1 interaction
PL3522878T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
GB2555733B (en) Electrical isolation to reduce magnetometer interference
PL3522876T3 (pl) Sposoby hamowania przemiany choliny w trimetyloaminę (tma)
PT3393517T (pt) Ácido acetilsalicílico para utilização no tratamento de influenza moderada a grave
GB2528112B (en) Improvements relating to inhibition of corrosion
IL250846A0 (en) Synthesis of cyclocreatin and its analogs
GB2583579B (en) Echo cancellation for time of flight analogue to digital converter
GB2534560B (en) Preparation of Composite Substrates
GB201820351D0 (en) Preparation of composite substrates